RMD — RESMED INC

NYSE · Health Care · Health Care Equipment & Supplies · CIK 943819 ·
Last close
$196.50
Market Cap
$28.50B
52W High
$234.21
52W Low
$180.27
ADV30
1,513,991
Next earnings
2026-04-30
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 1,431,406,000 890,979,000 499,810,000 398,732,000 8,784,285,000 1,660,513,000 2,292,374,000
Dec 2025 1,422,808,000 878,724,000 497,595,000 392,593,000 8,503,370,000 1,417,069,000 2,182,491,000
Sep 2025 1,335,582,000 820,820,000 462,347,000 348,536,000 8,308,352,000 1,383,848,000 2,187,088,000
Jun 2025 1,347,993,000 820,068,000 456,571,000 379,705,000 8,174,391,000 1,209,450,000 2,206,532,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,889,964,000
Investing CF
$-295,261,000
Financing CF
$-907,752,000
CapEx
$-153,701,000
Dividends Paid
$-340,162,000
Buybacks
$-600,045,000
EPS Diluted TTM
$10.37
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$6,958,779,000
Inventory
$911,876,000
Receivables
$1,045,943,000
ST Investments
EBIT TTM
$1,916,323,000
Pretax Income TTM
$1,903,306,000
Interest Exp TTM
Analysts
15

Yahoo Snapshot (yfinance, live)

Total Revenue
$5,537,788,928
EBITDA
$2,119,501,056
Free Cash Flow
$1,446,655,104
Enterprise Value
$26,926,139,392
Total Cash
$1,660,513,024
Total Debt
$843,169,024
Shares Out
145,056,384
Trailing EPS
$10.37
Book Value
$44.76
ROE
25.2%
ROA
14.7%
Div Yield
1.25%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Jun 2025 5,146,327,000 1,687,394,000 1,400,723,000 8,174,391,000 2,206,532,000 1,751,588,000
Jun 2024 4,685,297,000 1,384,121,000 1,020,951,000 6,872,394,000 2,008,351,000 1,401,260,000
Jun 2023 4,222,993,000 1,151,997,000 897,556,000 6,751,708,000 2,621,805,000 693,299,000
Jun 2022 3,578,127,000 1,002,150,000 779,437,000 5,095,853,000 1,735,102,000 351,147,000
Jun 2021

TTM Snapshot

Revenues TTM
$4,958,138,000
NetIncome TTM
$1,290,228,000
OpCashFlow TTM
$0
Assets (Latest)
$8,174,391,000
Forward EPS
$12.10

Max Pain — expiry 2026-07-17

max pain strike: $210.00 · spot: $196.50 · call oi: 1,702 · put oi: 5,436
Expected Move to 2026-07-17: ±$11.35 (5.78%) — implied range $185.15$207.85 · ATM straddle on $195.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
GEHC GE HealthCare Technologies Inc. $29.51B $64.88
DXCM DEXCOM INC $26.91B $69.75
MDLN Medline Inc. $30.48B $36.05
FSNUF Fresenius SE & Co. KGaA $30.61B $54.35
PHG KONINKLIJKE PHILIPS NV $25.98B $26.73

News headlines (Yahoo Finance, 1h cache)

[Latest] Global Neonatal Intensive Care Respiratory Devices Market Size/Share Worth USD 5.7 Billion by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast
2026-06-24 13:30 · Yahoo
1 Oversold Stock Primed to Rebound and 2 We Find Risky
2026-06-24 10:16 · Yahoo
Stocks making big moves yesterday: Nubank, Ocular Therapeutix, Mondelez, ResMed, and Sonos
2026-06-18 15:17 · Yahoo
Why ResMed (RMD) Shares Are Falling Today
2026-06-17 20:51 · Yahoo
Sector Update: Healthcare Stocks Retreat Late Afternoon
2026-06-17 19:38 · Yahoo
Stocks Mixed Ahead of FOMC Meeting Results
2026-06-17 15:22 · Yahoo
Stocks Supported by Chip Stock Strength and Strong US Retail Sales
2026-06-17 14:09 · Yahoo
Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls
2026-06-17 13:47 · Yahoo
Nasdaq Futures Climb as Chip Stocks Rebound Ahead of First Fed Decision Under Warsh
2026-06-17 10:37 · Yahoo
ResMed (RMD) Stock Valuation Check After Mixed Returns And Undervaluation Signals
2026-06-15 04:17 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.